Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Follow-Up Shiftability Study of Arbaclofen With an Open-Label Extension for the Study of Biomarkers in Children and Adolescents With Autism Spectrum Disorders.

NCT07655115 is registered in ClinicalTrials.gov with Hospital General Universitario Gregorio Marañon as lead sponsor.

NCT NCT07655115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07655115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Follow-Up Shiftability Study of Arbaclofen With an Open-Label Extension for the Study of Biomarkers in Children and Adolescents With Autism Spectrum Disorders.
Lead sponsor
Hospital General Universitario Gregorio Marañon
Phase
Phase 3
Overall status
Recruiting
Start date
November 20, 2025
Completion date
December 31, 2026
Enrollment
103 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorders